Atnaujinkite slapukų nuostatas

El. knyga: Carbohydrates as Drugs

  • Formatas: PDF+DRM
  • Serija: Topics in Medicinal Chemistry 12
  • Išleidimo metai: 14-Nov-2014
  • Leidėjas: Springer International Publishing AG
  • Kalba: eng
  • ISBN-13: 9783319086750
Kitos knygos pagal šią temą:
  • Formatas: PDF+DRM
  • Serija: Topics in Medicinal Chemistry 12
  • Išleidimo metai: 14-Nov-2014
  • Leidėjas: Springer International Publishing AG
  • Kalba: eng
  • ISBN-13: 9783319086750
Kitos knygos pagal šią temą:

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine. Therefore, the topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drugability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interact

ions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. In general, special volumes are edited by well known guest editors.

Carbohydrate-Based Synthetic Chemistry in the Context of Drug Design.- Iminosugars: Therapeutic Applications and Synthetic Considerations.- Computational Docking as a Tool for the Rational Design of Carbohydrate-Based Drugs.- Discovery and Development of Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Dapagliflozin for the Treatment of Type 2 Diabetes.- Design, Synthesis, and Applications of Galectin Modulators in Human Health.- Discovery and Application of FimH Antagonists.- Carbohydrate-Based Anti-Virulence Compounds Against Chronic Pseudomonas aeruginosa Infections with a Focus on Small Molecules.- The Evolution of a Glycoconjugate Vaccine for Candida albicans.

PETER H. SEEBERGER is Firmenich Assistant Professor of Chemistry at the Massachusetts Institute of Technology in Cambridge, Massachusetts.
Carbohydrate-Based Synthetic Chemistry in the Context of Drug Design
1(22)
Markus Leibeling
Daniel B. Werz
Iminosugars: Therapeutic Applications and Synthetic Considerations
23(30)
Graeme Home
Computational Docking as a Tool for the Rational Design of Carbohydrate-Based Drugs
53(20)
Martin Frank
Discovery and Development of Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Dapagliflozin for the Treatment of Type 2 Diabetes
73(22)
Alan Braem
Prashant P. Deshpande
Bruce A. Ellsworth
William N. Washburn
Design, Synthesis, and Applications of Galectin Modulators in Human Health
95(28)
Alison Mackinnon
Wei-Sheng Chen
Hakon Leffler
Noorjahan Panjwani
Hans Schambye
Tariq Sethi
Ulf J. Nilsson
Discovery and Application of FimH Antagonists
123(46)
Sebastien G. Gouin
Goedele Roos
Julie Bouckaert
Carbohydrate-Based Anti-Virulence Compounds Against Chronic Pseudomonas aeruginosa Infections with a Focus on Small Molecules
169(18)
Alexander Titz
The Evolution of a Glycoconjugate Vaccine for Candida albicans
187(48)
David R. Bundle
Index 235